Background: The riboprotein telomerase has been linked to cellular imm
ortality and is believed to play a key role in tumorigenesis. Objectiv
e: To determine if telomerase is expressed in patients with oral squam
ous cell carcinoma. Design: Twenty patient samples of oral squamous ce
ll carcinoma and 20 adjacent histologically normal mucosal samples wer
e assayed using the telomeric repeat amplification protocol (TRAP) met
hod for detection of telomerase activity. The leukemic tell line, K562
, was used as a positive control and the human fibroblast line, Hs21Fs
, as a negative control. Patients: Consecutive series of patients with
oral squamous cell carcinoma presenting to a tertiary referral center
. Main Outcome Measure: A sample was classified as telomerase positive
when an RNase-sensitive hexameric repeat ladder was observed. Absence
of laddering was considered a negative result. Results: Eighteen (90%
) of 20 tumor samples and 7 (35%) of 20 adjacent histologically normal
samples were telomerase positive. A statistically significant differe
nce was observed in telomerase activity for T1 and T2 cancers compared
with T4 cancers (P<.05 by analysis of variance). No statistically sig
nificant difference was observed in activity for T1 and T2 cancers vs
T3 cancers. Conclusions: The finding of telomerase activity in 90% of
tumor samples is consistent with the concept of telomerase playing a k
ey role in tumorigenesis. Further study is needed to determine the use
fulness of this enzyme as a molecular marker.